(Q40416729)

20 September 2017

title

LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2). (English)

1 reference

20 September 2017

1 reference

John So

1

1 reference

20 September 2017

Feng-qiang Wang

2

1 reference

20 September 2017

Jason Navari

3

1 reference

20 September 2017

Jeremy Schreher

4

1 reference

20 September 2017

David A Fishman

5

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

97

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

870-878

1 reference

Specific keynote: in the shadow of illness-supporting women with ovarian cancer

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

Lysophosphatidic acid: G-protein signalling and cellular responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

Lysophospholipids activate ovarian and breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

The bioactive phospholipid lysophosphatidic acid is released from activated platelets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

Clinical implications of expression of vascular endothelial growth factor in metastatic lesions of ovarian cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

The phagokinetic tracks of 3T3 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

Laminin inhibits human keratinocyte migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

Mechanism of Human Dermal Fibroblast Migration Driven by Type I Collagen and Platelet-derived Growth Factor-BB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

SU1498, an inhibitor of vascular endothelial growth factor receptor 2, causes accumulation of phosphorylated ERK kinases and inhibits their activity in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

Decay-accelerating factor induction on vascular endothelium by vascular endothelial growth factor (VEGF) is mediated via a VEGF receptor-2 (VEGF-R2)- and protein kinase C-alpha/epsilon (PKCalpha/epsilon)-dependent cytoprotective signaling pathway an

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

Proinvasive properties of ovarian cancer ascites-derived membrane vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

Lysophosphatidic Acid Stimulates Ovarian Cancer Cell Migration via a Ras-MEK Kinase 1 Pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

Induction of protein growth factor systems in the ovaries of transgenic mice overexpressing human type 2 lysophosphatidic acid G protein-coupled receptor (LPA2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

VEGF-receptor signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.004

10.1016/J.YGYNO.2005.03.004

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference